Concepedia

Publication | Closed Access

LBA69 Belzutifan, a HIF-2α Inhibitor, for von Hippel-Lindau (VHL) disease-associated neoplasms: 36 months of follow-up of the phase II LITESPARK-004 study

DOI

14

Citations

0

References

2022

Year

Ramaprasad Srinivasan, Othon Iliopoulos, W. Kimryn Rathmell, Veena M. Narayan, Benjamin L. Maughan, Stéphane Oudard, Tobi Else, Jodi K. Maranchie, Sarah J. Welsh, Ane B. Iversen,
Annals of Oncology

No additional data available for this publication yet. Check back later!